Nutrien Ltd.
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2023 · Filed Mar 1, 2024
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Share Repurchase Programs
Share Repurchase Programs
| Maximum · Maximum · Number of | |||||
|---|---|---|---|---|---|
| Commencement · Shares for · Shares for · Shares | |||||
| Date | Expiry | Repurchase | Repurchase (%) | Repurchased | |
| 2021 Normal Course Issuer Bid | March 1, 2021 | February 28, 2022 | 28,468,448 | 5 | 22,186,395 |
| 2022 Normal Course Issuer Bid 1 | March 1, 2022 | February 7, 2023 | 55,111,110 | 10 | 55,111,110 |
| 2023 Normal Course Issuer Bid | March 1, 2023 | February 29, 2024 | 24,962,194 | 5 | 5,375,397 |
| 2024 Normal Course Issuer Bid 2 | March 1, 2024 | February 28, 2025 | 24,728,159 | 5 | ‐ |
1 The original expiry date was February 28, 2023, but we acquired the maximum aggregate number of common shares allowable on February 7, 2023.
2 On February 21, 2024, our Board of Directors approved a share repurchase program. The 2024 normal course issuer bid, which is subject to acceptance by the Toronto Stock Exchange, will expire earlier than the date above if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.
Purchases under the normal course issuer bids were, or may be, made through open market purchases at market prices as well as by other means permitted by applicable securities regulatory authorities, including private agreements.
| Summary of share repurchases | 2023 | 2022 |
|---|---|---|
| Number of common shares repurchased for cancellation | 13,378,189 | 53,312,559 |
| Average price per share (US dollars) | 74.73 | 84.34 |
| Total cost | 1,000 | 4,496 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.